Pirfenidone antagonizes TGF-β1-mediated gabapentin resistance via reversal of desmoplasia and the ‘cold’ microenvironment in pancreatic cancer

Zhang, Jin; Zhang, Junrong; Lin, Ronggui; Hou, Ping; Zheng, Lihong; Jiang, Chenwei; Zhang, Da; Huang, Heguang; Teng, Tianhong

doi:10.1016/j.canlet.2024.217287

Cancer Letters

2024

DOI: 10.1016/j.canlet.2024.217287

|View full text |Cite

Pirfenidone antagonizes TGF-β1-mediated gabapentin resistance via reversal of desmoplasia and the ‘cold’ microenvironment in pancreatic cancer

Jin Zhang,

Junrong Zhang,

Ronggui Lin

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Targeting cancer-associated fibroblasts with pirfenidone: A novel approach for cancer therapy

Rastegar-Pouyani,

Abdolvahab,

Farzin

et al. 2024

Tissue and Cell

View full text Add to dashboard Cite

Targeting cancer-associated fibroblasts with pirfenidone: A novel approach for cancer therapy

Rastegar-Pouyani,

Abdolvahab,

Farzin

et al. 2024

Tissue and Cell

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Pirfenidone antagonizes TGF-β1-mediated gabapentin resistance via reversal of desmoplasia and the ‘cold’ microenvironment in pancreatic cancer

Cited by 1 publication

References 46 publications

Targeting cancer-associated fibroblasts with pirfenidone: A novel approach for cancer therapy

Targeting cancer-associated fibroblasts with pirfenidone: A novel approach for cancer therapy

Contact Info

Product

Resources

About